Home > Drug Search >
  • company_query: AriBio
  •   > 
Drug Filter
Category:
chemistry (11) biology (23)
Status:
Approved (1) BLA Filing (1) Phase Ⅲ (2) Phase Ⅱ (13) Phase Ⅰ (17)
Clinical Stage:
Pending (8) Active (19) Discontinued (6)
Bio-Type:
Gene therapy (2) Vaccine (11) Recombinant polypeptide (1) Recombinant cytokines (3) Bispecific antibody (1) Other recombinant protein (1) Whole antibody (1) ADC (1)
Indication:
Non-alcoholic steatohepatitis (1) Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (1) Alzheimer's disease (AD) (1) Amyotrophic lateral sclerosis (ALS) (1) Anemia (1) Breast cancer (1) ischaemic heart disorder (1) Community-acquired pneumonia (CAP) (1) Cutaneous T cell lymphoma (CTCL) (1) Respiratory-tract disorders (1) Cystic fibrosis (CF) (1) Dementia (1) Bronchitis (1) Diabetic nephropathy (1) Diarrhea (1) Infections of the eye (1) HCV infection (1) HIV infection (2) Bronchopulmonary dysplasia (1) Rabies (2) Lymphoma (1) Melanoma (2) Myocardial infarction (MI) (1) Non small cell lung cancer (NSCLC) (1) Pancreatic cancer (1) Parkinson's disease (PD) (1) Peripheral arterial disease (PAD) (1) Postherpetic neuralgia (PHN) (1) Post-polycythemia vera (1) Prostate cancer (3) Solid tumours (2) Thrombocytopenia (1) Tuberculosis (1) Type 2 diabetes (1) Ulcerative colitis (1) Erythema (1) Colorectal cancer (1) Systemic inflammatory response syndrome (SIRS) (1) Diabetes (1) Type 1 diabetes (2) Mesothelioma (1) Celiac disease (1) Myocardia ischemia (1) Stomatitis (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top